The Cooper Companies, Inc. (NASDAQ:COO) Shares Sold by Whittier Trust Co.

Whittier Trust Co. decreased its holdings in shares of The Cooper Companies, Inc. (NASDAQ:COO) by 44.4% during the 1st quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 6,613 shares of the medical device company’s stock after selling 5,288 shares during the quarter. Whittier Trust Co.’s holdings in Cooper Companies were worth $558,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in COO. T. Rowe Price Investment Management Inc. increased its position in shares of Cooper Companies by 2.1% during the fourth quarter. T. Rowe Price Investment Management Inc. now owns 7,678,965 shares of the medical device company’s stock worth $705,928,000 after acquiring an additional 155,233 shares during the last quarter. JPMorgan Chase & Co. increased its position in shares of Cooper Companies by 1.5% during the fourth quarter. JPMorgan Chase & Co. now owns 5,004,523 shares of the medical device company’s stock worth $460,066,000 after acquiring an additional 74,501 shares during the last quarter. Geode Capital Management LLC increased its position in shares of Cooper Companies by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 4,906,463 shares of the medical device company’s stock worth $449,907,000 after acquiring an additional 109,907 shares during the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Cooper Companies by 517.0% during the fourth quarter. Price T Rowe Associates Inc. MD now owns 3,529,477 shares of the medical device company’s stock worth $324,466,000 after acquiring an additional 2,957,421 shares during the last quarter. Finally, Norges Bank bought a new stake in Cooper Companies in the fourth quarter valued at about $217,906,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Analysts Set New Price Targets

A number of equities research analysts recently issued reports on COO shares. JPMorgan Chase & Co. reiterated a “neutral” rating and issued a $76.00 price objective (down from $110.00) on shares of Cooper Companies in a report on Friday, May 30th. Mizuho cut their price objective on shares of Cooper Companies from $105.00 to $90.00 and set an “outperform” rating for the company in a research report on Wednesday. Wells Fargo & Company cut their price objective on shares of Cooper Companies from $118.00 to $93.00 and set an “overweight” rating for the company in a research report on Friday, May 30th. Wall Street Zen lowered shares of Cooper Companies from a “buy” rating to a “hold” rating in a research report on Saturday, July 12th. Finally, Loop Capital set a $100.00 price target on shares of Cooper Companies in a research report on Tuesday, June 17th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Moderate Buy” and a consensus price target of $97.20.

Cooper Companies Stock Up 0.8%

Shares of COO stock opened at $73.26 on Friday. The Cooper Companies, Inc. has a 52-week low of $65.00 and a 52-week high of $112.38. The stock has a market cap of $14.65 billion, a price-to-earnings ratio of 35.56, a PEG ratio of 1.77 and a beta of 0.99. The firm’s 50-day moving average is $74.23 and its 200-day moving average is $82.18. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.23 and a current ratio of 2.10.

Cooper Companies (NASDAQ:COO) last announced its quarterly earnings results on Thursday, May 29th. The medical device company reported $0.96 EPS for the quarter, beating analysts’ consensus estimates of $0.93 by $0.03. Cooper Companies had a net margin of 10.39% and a return on equity of 9.60%. The business had revenue of $1 billion for the quarter, compared to analyst estimates of $995.12 million. During the same quarter in the prior year, the business earned $0.85 EPS. Cooper Companies’s quarterly revenue was up 6.3% on a year-over-year basis. Sell-side analysts predict that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.